Intellectual Property Cases filed in the Third Circuit Courts
Cases 31 - 40 of 160
MYLAN TECHNOLOGIES, INC. et al v. NOVARTIS PHARMACEUTICALS CORPORATION
as 2:2018cv12022
Plaintiff: MYLAN N.V., MYLAN TECHNOLOGIES, INC., MYLAN PHARMACEUTICALS INC. and others
Defendant: NOVARTIS PHARMACEUTICALS CORPORATION
Cause Of Action: Motion to Compel
Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv01777
Plaintiff: Noven Pharmaceuticals, Inc.
Defendant: Mylan Technologies Inc. , Mylan Pharmaceuticals Inc. , Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 271
SANOFI-AVENTIS U.S. LLC et al v. MYLAN N.V. et al We have downloadable decisions or orders for this case
as 2:2017cv09105
Plaintiff: SANOFI-AVENTIS U.S. LLC , SANOFI-AVENTIS DEUTSCHLAND GMBH and SANOFI WINTHROP INDUSTRIE
Defendant: MYLAN N.V. , MYLAN GMBH , MYLAN INC. and others
Cause Of Action: 35 U.S.C. § 271
SANOFI-AVENTIS U.S. LLC et al v. MYLAN N.V. et al
as 3:2017cv09105
Plaintiff: SANOFI-AVENTIS U.S. LLC , SANOFI-AVENTIS DEUTSCHLAND GMBH and SANOFI WINTHROP INDUSTRIE
Defendant: MYLAN N.V., MYLAN GMBH, MYLAN INC. and others
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al
as 2:2017cv06714
Plaintiff: VALEANT PHARMACEUTICALS INTERNATIONAL, INC. , SALIX PHARMACEUTICALS, INC. , PROGENICS PHARMACEUTICALS, INC. and others
Defendant: MYLAN PHARAMACEUTICALS, INC., MYLAN LABORATORIES LTD. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al We have downloadable decisions or orders for this case
as 2:2017cv03387
Plaintiff: CELGENE CORPORATION
Defendant: HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv00322
Plaintiff: UCB, Inc. , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Defendant: Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant: Mylan Pharmaceuticals, Inc. , Mylan Technologies, Inc. and Mylan, Inc.
Counter_defendant: LTS Lohmann Therapie-Systeme AG , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv00249
Plaintiff: Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant: Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00113
Plaintiff: Amgen Inc.
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN N.V. et al
as 1:2017cv00392
Plaintiff: OTSUKA PHARMACEUTICAL CO., LTD.
Defendant: MYLAN N.V., MYLAN INC. and MYLAN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?